About: the report that niprd has developed niprimune for the treatment of  covid-19 is misleading as the drug -niprimune- is yet to conclude clinical trials to test it efficacy as a treatment for covid-19. as it stands, niprmune is an immune booster and not a cure or treatment for covid-19.     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:Rating, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:name
  • the report that niprd has developed niprimune for the treatment of  covid-19 is misleading as the drug -niprimune- is yet to conclude clinical trials to test it efficacy as a treatment for covid-19. as it stands, niprmune is an immune booster and not a cure or treatment for covid-19.
schema:sameAs
schema:ratingValue
  • The report that NIPRD has developed Niprimune for the treatment of  COVID-19 is MISLEADING as the drug -Niprimune- is yet to conclude clinical trials to test it efficacy as a treatment for COVID-19. As it stands, Niprmune is an immune booster and not a cure or treatment for COVID-19.
schema:author
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 2 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software